Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acebilustat in Treatment of Human Upper Extremity Lymphedema
NCT05203835Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acebilustat in lymphedema, sponsored by Stanford University. Started Jul 2022; status: completed.
02
Drugs
acebilustat
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT05203835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05203835.